“…In clinical settings, patients with structural heart disease and electrophysiological remodeling are at highest risk for drug induced arrhythmia. Experimental work showed that cardiomyocytes isolated from structural heart disease patients with a history of ventricular tachycardia were significantly more prone to the development of EADs (Coppini et al, 2013), and EADs were frequently observed in whole heart experimental recordings of aged or diseased animals, as well as in human whole ventricle simulations Milberg et al, 2012;Dutta et al, 2016;Van Nieuwenhuyse et al, 2017). In this study we considered an optimized population of models with low repolarization reserve, including weak I Kr , I Ks , and I NaK , together with strong I NaL , I CaL , and I NaCa , which are observed in multiple diseases, such as long QT syndrome (Schwartz Peter et al, 2012), hypertrophic cardiomyopathy (Coppini et al, 2013), and heart failure (Shamraj et al, 1993;Ambrosi et al, 2013).…”